The potential of synthetic peptides for vaccines
Steward, M.W.; Howard, C.R.
Medical Laboratory Sciences 42(4): 376-387
1985
ISSN/ISBN: 0308-3616 PMID: 2417087 Document Number: 258054
Document emailed within 1 workday
Related Documents
Salman, A.M.; Abdel-Ghaffar, A.B.; El-Sheikh, N.; Andersen, P.; Egiza, A.O. 2012: Evaluation of immunodiagnostic potential of ESAT-6 synthetic peptides mixture in Egyptian pulmonary tuberculosis patients Egyptian Journal of Immunology 19(1): 19-30Khobarekar, B.G.; Vernekar, V.; Raghavan, V.; Kamada, M.; Maegawa, M.; Bandivdekar, A.H. 2008: Evaluation of the potential of synthetic peptides of 80 kDa human sperm antigen (80 kDaHSA) for the development of contraceptive vaccine for male Vaccine 26(29-30): 3711-3718
Brondz, B.D.; Anafalova, T.V.; Pavlova, L.S.; Pankratova, E.V.; Kozhich, A.G.; Moshnikov, S.A. 1993: Use of a series of synthetic peptides and purified major histocompatibility complex i (H-2K(b)) molecules for inhibiting T-suppressors, specific for the K(b) molecule, and their induction by peptides in vivo Molekuliarnaia Biologiia 27(4): 773-780
Krivorutchenko, I.L. 1999: Use of muramyl peptides in viral vaccines Voprosy Virusologii 44(1): 4-8
Paiva, A.C. 1973: Synthetic angiotensin inhibiting peptides Acta Physiologica Latino Americana 23(6): 530-532
Kazakova, O.V.; Orekhovich, V.N. 1982: Hydrolysis of synthetic peptides by group D cathepsins Biokhimiia 47(9): 1448-1453
Sergeyev, O.V.; Barinsky, I.F. 2016: Synthetic Peptide Vaccines Voprosy virusologii 61(1): 5-8
Perrin, L.H.; Simitsek, P.; Fasani-Ghersa, P. 1989: Asexual blood stage vaccines: from merozoites to peptides Transactions of the Royal Society of Tropical Medicine and Hygiene 83(Suppl): 53-56
Pessi, A.; Bianchi, E.; Chiappinelli, L.; Bonelli, F.; Tougne, C.; Lambert, P.H.; Del Giudice, G. 1991: Multiple antigen peptides (MAPs) as candidate vaccines against malaria Parassitologia 33(1): 79-84
Kulik, L.N.; Ivanov, V.S.; Chikin, L.D.; Berkova, N.P.; Kozhich, A.T.; Gabriélian, A.E.; Ivanova, V.T. 1994: Modeling antigenic determinants of the hepatitis a virus using synthetic peptides Bioorganicheskaia Khimiia 20(7): 709-719
Widmann, C.; Maryanski, J.L.; Romero, P.; Corradin, G. 1991: Differential stability of antigenic MHC class I-restricted synthetic peptides Journal of Immunology 147(11): 3745-3751
Lasarte, J.J.; Sarobe, P.; Golvano, J.; Prieto, I.; Civeira, M.P.; Gullón, A.; Sarin, P.S.; Prieto, J.; Borrás-Cuesta, F. 1994: CD4-modified synthetic peptides containing phenylalanine inhibit HIV-1 infection in vitro Journal of Acquired Immune Deficiency Syndromes 7(2): 129-134
Del Giudice, G.; Biro, S.; Degrémont, A.A.; Engers, H.D.; Lambert, P.H.; Pessi, A.; Tougne, C.; Verdini, A.S.; Weiss, N.; Tanner, M. 1986: Detection of antibodies to Plasmodium falciparum sporozoites by employing synthetic peptides Parassitologia 28(2-3): 107-111
Białek, M.; Grabowski, S.; Kamiński, Z.; Kaca, Wław. 2006: Synthetic peptides mimicking antigenic epitope of Helicobacter pylori urease Acta Biochimica Polonica 53(1): 83-86
Motté, P.; Alberici, G.; Ait-Abdellah, M.; Bellet, D. 1987: Monoclonal antibodies distinguish synthetic peptides that differ in one chemical group Journal of Immunology 138(10): 3332-3338
Rowe, P.M.; Link, W.T.; Hazra, A.K.; Pearson, P.G.; Albers, R.W. 1988: Antibodies to synthetic peptides as probes of the structure of the alpha subunit of the Na,K-ATPase Progress in Clinical and Biological Research 268a: 115-120
Lottersberger, J.; Salvetti, J.L.; Beltramini, L.M.; Tonarelli, G. 2004: Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins Revista Argentina de Microbiologia 36(4): 151-157
Sanui, H.; Gery, I. 1991: Analysis of immune responses of uveitogenic synthetic peptides derived from IRBP Nippon Ganka Gakkai Zasshi 95(2): 147-151
Semiletov, I.A.; Pimenov, V.K.; Ianina, M.V.; Zubov, S.V.; Shibnev, V.A. 2002: Test for specific antibodies to virus hepatitis delta based on synthetic peptides Voprosy Virusologii 47(6): 21-24
McKee, R.L.; Caulfield, M.P. 1989: Synthetic peptides as tools for investigating the pathogenicity of disease: humoral hypercalcemia of malignancy Peptide Research 2(2): 161-166